Fairvalue-Calculator Fairvalue-Calculator
EN DE

H.PIO Co (357230) Fair Value & Analysis

Consumer Non-Cyclicals · KR · Market cap 93.3B KRW

Price2,070 KRW
Fair Value3,745 KRW
Upside+80.9%
Quality80/100
Evidence: Medium Range 2,625 KRW – 4,868 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

H.PIO Co (357230) currently trades at 2,070 KRW, while our model-based Fair Value estimate is 3,745 KRW — implying the stock looks roughly 80.9% undervalued today. We read business quality at 80/100 (high quality), in the Consumer Non-Cyclicals sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

H.PIO Co., Ltd. manufactures and sells health functional foods worldwide. It offers dietary and mixed vitamin supplements. The company was founded in 2012 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

FB (FB) +13% URC (URC) -23% MONDE (MONDE) -84% CNPF (CNPF) +76% DNL (DNL) +40% RFM (RFM) +93%

Frequently asked questions

Is H.PIO Co (357230) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 3,745 KRW versus a price of 2,070 KRW — about +81% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 357230?
Our 21-model fair value for H.PIO Co is 3,745 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 2,070 KRW.
What is the quality score of 357230?
H.PIO Co has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.